Overview

Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis

Status:
Terminated
Trial end date:
2012-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of Anti-MIF Antibody in subjects with lupus nephritis.
Phase:
Phase 1
Details
Lead Sponsor:
Baxalta now part of Shire
Baxalta US Inc.
Treatments:
Antibodies
Immunoglobulins